Solventum (SOLV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Solventum reported Q3 2026 revenue of $1.95 billion, down 7% year-over-year, slightly missing the $1.97 billion consensus estimate. However, EPS of $1.45 beat expectations with a +7.41% surprise versus the $1.35 estimate. The company showed mixed performance across segments, with MedSurg and Health Information Systems posting modest gains, while Dental Solutions declined 6.8%. The stock has a Zacks Rank #3 (Hold) rating.